Introduction
Mimicry of a complex biological system ex vivo is a challenging task, generally limited in the extent to which either normal or pathological processes can be modeled. This is particularly true of the human placenta, which is characterized by tightly regulated trophoblast differentiation events during the first trimester of pregnancy, and complex dysregulation in pathological pregnancy. Early placental development (<8-10 weeks of gestation) occurs under low oxygen conditions (15-20 mmHg or 2% O 2 ), when the intervillous space is separated from the maternal uterine circulation by endovascular trophoblastic plugs obstructing the opening of uteroplacental arteries (1) . This low O 2 environment is critical for early embryonic development. At 8 to 10 weeks of gestation, endovascular invasion ensues.
Oxygen tension is known to regulate this process (2) (3) (4) . Invasion coincides with progressive dislocation of endovascular plugs, giving rise to a dramatic increase in O 2 tension within the intervillous space reaching 55-60 mmHg ( 8% O 2 ) at the initial stages of intervillous perfusion (5) .
This decreases to a mean of approximately 40 mmHg towards the end of the third trimester as a result of increasing O 2 extraction from the placenta and the fetus. Various locations within the same placenta are differentially perfused as central regions (proximal to the umbilical cord) are more oxygenated when compared to distal/peripheral organ sites (6) . Hence, villous trophoblast cells can encounter fluctuations in O 2 tension depending on their spatial location and upon blood flow (6) . These developmental and hemodynamic events, regulated by O 2 throughout placental development, act synergistically to regulate placental development and ensure a healthy outcome. Failure of the oxygenassociated developmental events contributes to placental disease (7) (8) (9) .
Abnormal first trimester trophoblast differentiation is associated with pregnancies complicated by preeclampsia and/or intrauterine growth restriction (IUGR). Preeclampsia, a disorder unique to humans, affects 5-10% of all pregnancies, and remains a leading cause of fetal and maternal morbidity and mortality (10, 11) . A key histopathologic correlation is shallow invasion and aberrant remodeling of maternal spiral arteries, which leads to decreased uteroplacental perfusion. Reduced perfusion in the preeclamptic placenta has been linked to inflammatory processes, oxidative stress and even infarctions (12, 13) . Experimental hypoxia is correlated with preeclampsia features, inducing trophoblast cell death, release of pro-inflammatory cytokines, and oxidative stress (7, (14) (15) (16) . The putative effect of reduced oxygenation on global gene expression changes in placental tissues from preeclamptic patients remains unclear.
In vitro methods mimicking the effects of reduced oxygen in the human placenta are important if we are to understand the dysregulated molecular events characteristic of preeclampsia and IUGR.
Several models are commonly used, including transformed cell lines, primary isolated cytotrophoblast cells and organ culture. However, there is substantial disagreement as to the relevance and utility of these models. We have therefore attempted a systematic comparison of global patterns of gene expression in 1) in vitro first trimester chorionic villous explants cultured under low and high O 2 conditions, 2) high-altitude placental tissue as an in vivo model of chronic hypoxia, and 3) preeclampsia, a complex disorder widely believed to be associated with placental hypoxia. Using unbiased gene profiling we found that aberrant gene expression in preeclampsia may be the result of reduced oxygenation and that placental explants under low oxygen and high altitude placenta mimic this situation.
Materials and Methods

Tissue Sampling
Tissue collections were performed in compliance with participating institutions' Ethics Guidelines and in accordance with the guidelines in The Declaration of Helsinki. Each participant provided written informed consent. First-trimester human placental tissue (5-6 weeks of gestation, n = 10; 12-13 weeks of gestation, n = 12) was obtained from elective terminations by dilatation and curettage. Preeclamptic placentae (PE; n = 11 including 2 complicated by IUGR, and 1 complicated by HELLP (Hemolysis Elevated Liver enzymes and Low Platelets), 10 non-labour, 1 labour) and preterm normotensive age-matched control placentae (AMC; n = 9, 4 mutiplets and 5 preterm labour, all in labour) were collected from deliveries at Mount Sinai Hospital. High altitude (HA) and moderate altitude (MA) placental samples (n = 8 each) were collected from normal, healthy pregnancies with spontaneous vaginal deliveries in women living at 3100m and 1600m in Colorado, USA. The Leadville group (3100m) exhibited decreased overall birth weights relative to MA pregnancies (1600m). Ten term placentae, obtained from cesarean deliveries without labour (C/S group) in healthy normotensive patients at sea level (Toronto, Canada), were also included as an additional control group. As well, 5 term normal healthy placentae were used as a neutral internal reference control allowing for normalization of microarray data across various chips. The C/S group and the term reference group were normal and within healthy physiologic range for all maternal and fetal clinical parameters. Due to organ heterogeneity, multiple specimens were sampled from central and peripheral regions and from both the maternal and fetal sides of term and age-matched control placentae. Areas with calcified, necrotic or visually ischemic tissue were omitted from sampling. The preeclamptic group was selected to represent classic severe early onset preeclampsia according to both clinical and pathological criteria based on the American College of Obstetrics and Gynecology (ACOG) criteria (17). All preterm and term control groups did not show clinical or pathological signs of preeclampsia, infection or other maternal or placental disease. Clinical parameters for preeclamptic, preterm agematched, moderate and high altitude participants are summarized in Table 1 .
Human Chorionic First Trimester Villous Explant Culture.
First-trimester explant culture was performed as described previously (3, 18) . Explants were maintained at 37°C in either standard tissue culture condition (5% CO 2 in 95% air) or maintained in an atmosphere of 3% O 2 /92% N 2 /5% CO 2 for 48 hrs. Four sets of explants from 4 different placentae were used. A minimum of 9 explants per experimental condition (3% O 2 vs. 20% O 2 ) were examined.
RNA Isolation
Total RNA was isolated from individual placentae using an RNeasy kit (Qiagen). RNA quality and integrity was checked on denaturing 1.2% agarose gel. Only RNA samples demonstrating 28S to 18S rRNA ratio of 2:1 (as determined by densitometric analysis) were included in study. RNA was prepared to a final concentration of at least 1 µg/µL.
Microarray Experiments and Analyses
Figure 1 summarizes how microarray experiments were conducted. The labeling and hybridization procedures were according to University Health Network Microarray Centre's indirect labeling protocol (http://www.microarrays.ca/support/proto.html). Tissue samples were pooled for the microarray experiments. The purpose of a pooling strategy was two fold. First, this strategy enabled thorough sampling, as multiple samples from the same experimental condition were combined.
Second, pooling increases the signal to noise ratio within the expression dataset, diminishing the false positive discovery rate for clusters of differentially or similarly expressed genes across different experimental conditions (19). All cyanine-3 labeled experimental samples were compared to the same neutral pooled RNA sample, obtained from five term placentae acquired from vaginal deliveries of normotensive healthy women (reference RNA). The purpose of choosing a pooled reference sample was to introduce a basic normalization parameter, which improves the reliability of gene expression comparison across different experimental conditions as well as arrays (19). An equal amount of RNA (10 µg) of each individual test sample from each experimental condition was pooled. Fluorophorelabeled cDNA was hybridized to 1.7k version 4 human microarrays, containing 1700 double spotted well-characterized human genes (http://www.microarray.ca; for a complete list of genes and related information spotted on 1.7k version 4 arrays refer to http://www.microarrays.ca/support/glists.html).
Arrays were scanned using a GenePix 4000 Microarray Scanner and spot density was analyzed using the GenePix Pro 4.0 Acquisition and Analysis software (Axon Instruments, CA). Global gene expression profiling and data visualization was performed using the Binary Tree-Structured Vector Quantization (BTSVQ; http://www.cs.toronto.edu/~juris/btsvq/downloads.html) software as previously described (20). BTSVQ performs unsupervised clustering of full gene expression profiles, and supports intuitive visualization of obtained clusters, both as a binary tree and component planes of Self-Organizing Maps (SOMs). Additionally, genes in 2 highly conserved areas of Self-Organizing Maps (SOMs) between 3% O 2 -treated explants, HA and preeclamptic placentae were selected for further analysis. Genes within these 2 areas within these hypoxia groups were subjected to statistical analysis to obtain lists of genes that were statistically similar to one another (amongst 3% explants, PE and HA), but significantly different from their respective control samples, i.e., 20%-treated explants, MA and AMC samples. Differential significance between two experimental conditions (i.e. HA vs MA) was defined at a 95% confidence interval with a p value < 0.05 as determined by Student's twoway t test performed for individual genes (spotted twice on 2-3 different arrays). As previously reported, a pseudocolor matrix was generated with the Matlab R12 software (MathWorks Inc., Natick, MA) in order to display the correlation between representative samples from the 3 hypoxic conditions (3% explants, HA and PE) and their controls (21).
Quantitative real-time PCR
To test whether pooled samples versus individual samples would differ significantly when analyzed for gene expression, the vascular endothelial growth factor (VEGF) and the integrin α6
Assay-on-Demand Taqman probes and primers (Applied Biosystems, CA) were used in quantitative real-time PCR (qPCR) analyses to validate differential gene expression as predicted by the BTSVQ and statistical analyses. Analysis was done using the DNA Engine Opticon®2 System (MJ Research) and data were normalized against expression of 18S ribosomal RNA as previously described (22).
Each individual sample that had been combined in the pooled experimental sample as well as the pooled sample used in the array experiment was assessed for differential gene expression. qPCR analyses were performed using three replicates of each condition at all times. Statistical significance was determined by Student's t test, significance is defined as p < 0.05.
Results
Unsupervised Clustering using Binary Tree-Structured Vector Quantization (BTSVQ)
Algorithm
The raw data using full gene expression profiles (first trimester and third trimester tissues) was subjected to an unsupervised analysis using BTSVQ software. BTSVQ combines a partitive k-means clustering and a self-organizing maps (SOM) algorithm to achieve unsupervised clustering of both samples and genes. This type of unsupervised analysis divides the Parent dataset (data from all arrays using all gene expressions) into a binary cluster tree by iteratively using a k-means algorithm with k=2 ( Figure 2A ). SOM was then applied to clustered samples based upon their quantified gene expression profiles. Partitive clustering results were cross-verified with the clusters generated by SOMs.
Clustered genes, represented using SOMs were then used to identify differentially expressed genes, and to visualize the global pattern of the two physiological hypoxia models (high altitude and explants cultured at 3% oxygen) and the pathological hypoxia (preeclampsia) samples. For each level of the binary tree, the genes are ranked both with respect to the likelihood of the gene being differentially expressed across all the samples in the same cluster and t-statistics. This provides an accurate method of excluding genes with variable expression across samples, as well as genes with low significance, and thus enables selection of the most differentiating genes between clusters. The cluster structure in gene space is visualized using component planes of the already computed SOM. To help diminish the noise in microarray experiments (largely due to hybridization, washing, scanning, spot-density analysis, array spotting variability, etc) and increase statistical power, we repeated arrays in duplicate or triplicate for each experimental condition. Figure 2B (lower left panel)
demonstrates the reproducibility and consistency of multiple, replicate arrays derived from the same sample. We also tested whether pooling vs. examination of individual samples would bias the results.
Global microarray expression profiling (BTSVQ and statistical analyses) demonstrated that VEGF transcript, a known hypoxia-induced gene (23), was differentially expressed between explants cultured under 3% and 20% O 2 (3%: 1 fold increase, p=0.0297), between high versus moderate altitude placentae (HA: 1.7 fold increase, p=0.0437) as well as in preeclamptic relative to age-matched control tissues (PE: 2.5 fold increase, p=0.0463), increasing in conditions of hypoxia. Using qPCR, we demonstrated that VEGF expression was in fact significantly increased in preeclampsia and 3% explants relative to their respective controls demonstrating the validity of the expression profiling ( Figure 2C) . Importantly, the data further demonstrates that there is no difference in the results Figure 2D demonstrates that Integrin α6 expression is in fact significantly increased in 3% explant, PE and HA groups relative to 20% explant, AMC and MA samples, once again validating the accuracy of the expression profile analyses. Furthermore, global array analysis showed increased expression of a number of genes known to be regulated by hypoxia inducible factor 1 (HIF-1) in all three hypoxia experimental conditions tested (Table 2) . Figure 3A) . Figure 3B shows the gene expression pattern in moderate and high altitude placentae, with noticeable differences in expression profile between the two, and between those at sea level (3C, term cesarean deliveries and vaginal deliveries). When preeclamptic (PE) and normotensive preterm age-matched controls (AMCs) were compared, we also observed noticeable differences in their global gene expression profiles ( Figure 3C center and right panel). It is important to emphasize that the AMC group is not a perfect control group as most patients within this group suffer from preterm labor. As well, it has been reported that placentae from preterm labor pregnancies exhibit a certain degree of histological similarity to those obtained from preeclamptic pregnancies (24). Moreover, the AMC group also includes four twin pregnancies. Multiple pregnancies are known to be associated with increased risk for developing preeclampsia (25). Thus, it is virtually impossible to compare gene expression obtained from the early severe onset PE group to that of a perfect (non-pathological) age-matched control group. Additionally, we also observed alterations in the global gene expression pattern between the term C/S and preterm labour (AMCs) groups ( Figure 3C left and middle panels) . The changes observed between these two control groups (C/S vs AMC) may be attributed to differences in mean gestational age, presence of underlying pathology (leading to preterm labor) as well as absence versus presence of spontaneous labour. Future studies are needed to address this issue.
Expression Profile Differences and Similarities
Finally, there was striking similarity between the expression profiles of all 3 experimental models a priori deemed relevant to hypoxia. First trimester explants exposed to 3% O 2, placental tissues obtained from high altitude pregnancies and preeclamptic tissues were all remarkably similar to one another ( Figure 3D) . These data collectively demonstrate that global gene expression in preeclampsia may be affected by reduced oxygenation, and most importantly that this complex pathology can be mimicked by in vitro and in vivo models of placental hypoxia. Global gene expression analyses further demonstrated that the percentage of unchanged genes between HA vs. 3%, PE vs. HA and 3% vs. PE was respectively, 90.4%, 94.4% and 90.8%. We have also performed correlation studies to determine the degree of similarity between the three hypoxia conditions (3% explants, HA and PE) both graphically and numerically. Figure 3E depicts a graphical correlation matrix demonstrating a positive significant correlation coefficient between 3% explants and HA conditions (r = 0.43; p<0.001). A stronger correlation was observed between HA and PE (r = 0.5; p<0.001) and particularly between 3% explants and PE (r = 0.6; p<0.001). These data further demonstrate that our in vitro and in vivo models of placental hypoxia can successfully mimic a global gene expression profile similar to that of preeclamptic placentae. Of interest, HA conditions showed no correlation relative to its control MA, while low correlation between PE and AMC was noted.
Furthermore, positive correlation between explants maintained at either 3% or 20% oxygen was observed. The latter was not surprising since the same tissues from the same placentae were used in explant cultures.
Clusters of Similarly and Differentially Expressed Genes
In addition to performing global expression analyses, we also selected two highly conserved areas between the SOMs of 3%-O 2 treated explants, high altitude and preeclamptic placentae and examined the similarly and differentially expressed genes contained within these two regions ( Figure   4A , areas A and B). Areas A and B were selected because they differ markedly from their respective controls (20% O 2 treated explants, moderate altitude and age-matched control placentae). The list of genes contained within areas A and B was subsequently retrieved and subjected to statistical analysis to yield commonly expressed genes between the 3 different hypoxic conditions. The table in Figure 4B depicts the list of similarly expressed genes in areas A and B between the three conditions shown in Figure 4A . In addition, we have included a list of differentially expressed genes (including fold changes and p value) in areas A and B, which are increasing in the three hypoxia conditions relative to their respective controls ( Figure 5 ).
Discussion
The main objective of this study was to assess, using a high-throughput genomic approach, the relevance of in vitro and in vivo models of placental hypoxia for mimicking and studying gene expression affected by reduced oxygenation, and to relate these findings to placentae affected by trophoblast-related disorders. The results clearly demonstrate the utility of the cultured explant and high altitude placental models for understanding global patterns of gene expression under reduced oxygen.
During in vivo placental development and prior to the opening of the intervillous space, placentation is known to occur in a low-oxygen environment, required for normal placental and embryonic development (26). In vitro, extravillous trophoblast cells in a low oxygen environment maintain a non-invasive, proliferative phenotype and low pO 2 inhibits differentiation of extravillous trophoblast cells along the invasive pathway (2, 3, 8) . Failure of differentiation to the invasive phenotype is thought to compromise remodeling of maternal myometrial spiral arteries and may predispose the developing placenta to a state of chronic or intermittent hypoxia and/or oxidative stress, as it is the case in preeclamptic placentae (14, (27) (28) (29) . That hypoxia and/or oxidative stress are important in this pregnancy disorder is demonstrated on the organismic level by reduced uteroplacental perfusion (Doppler studies), at the organ level by markers of hypoxia and at the molecular level by an accumulating body of evidence suggesting dysregulations in HIF-1α expression in preeclampsia (4, 30-32). These findings underline the importance of investigating the global effects of reduced oxygenation on trophoblast biology using relevant experimental models.
The use of placental explant models has been previously subjected to debate (33, 34). In this study we have demonstrated the suitability, reliability and power of an in vitro first trimester human placental explant model as well as a naturally occurring high altitude model of placental hypoxia for studying the global effects of reduced oxygenation in placental tissues. Using unbiased global gene expression profiling we have shown that extrapolating findings from these models and applying them to an in vivo pathologic context is a reasonable and reproducible strategy for the study of oxygen effects on placental gene expression, in two distinct but biologically relevant experimental models.
After the opening of the intervillous space, the oxygen level within the placenta is approximately 6-8% (5). However, our results support that using 20% O 2 as a standard control condition in first trimester explant studies is relevant to the in vivo situation at the end of the first trimester (after the opening of the intervillous space to maternal blood). In preeclampsia, placental perfusion can be decreased 50-70% (35) potentially resulting in an intervillous oxygen concentration of approximately 2-4% (36). It is not surprising, therefore, to observe the close similarity in global gene profiling between explants incubated under 3% oxygen and preeclamptic placental tissues. These data represent the first large-scale molecular evidence that global gene expression in preeclampsia is re-capitulated by reduced oxygenation, and that an immature trophoblast phenotype reminiscent of early first trimester gestation (< 8 weeks of gestation) is maintained (2, 3).
Placentation at high altitude has recently emerged as a natural in vivo model for studying the hypoxia-related aspect of placental pathologies such as preeclampsia and IUGR. Placentae from high altitude pregnancies (>3000m) have decreased uterine arterial remodeling, less uteroplacental arterial invasion, increased proliferation of villous cytotrophoblast cells, decreased uteroplacental perfusion and increased circulating levels of pro-inflammatory cytokines and catecholamines, similar to what is observed in preeclampsia (36, 37). In addition, the incidence of preeclampsia and IUGR is increased by 2-4 fold in pregnancies above 2700 m accompanied by maternal physiological changes of pregnancy that appear intermediate between normal pregnancy and preeclampsia (36). Gene profiling revealed a dramatic resemblance in the global gene expression profile between placentae from high altitude pregnancies and first trimester villous explants kept at 3% oxygen. The striking similarity between these two conditions is likely due both to lowered PaO 2 of the maternal blood entering the intervillous space and to reduced uterine arterial blood flow (~ 30%) in high altitude pregnancies when compared to sea level (36). Our data demonstrates the first in vivo physiological effect of reduced oxygenation on global gene expression in high altitude placentae. The resemblance between the 3% O 2 first trimester explants, the preeclamptic and the high altitude tissue supports the argument that hypoxia induces or maintains a relatively immature trophoblast phenotype.
The primary objective of our work was not to identify specific differential gene expression but rather to identify clusters of genes that may be similarly expressed in conditions of in vivo and in vitro placental hypoxia and relate these clusters to a pathologic state affected by aberrant placental oxygenation (preeclampsia). After global gene expression analyses of the entire set of arrays, we identified a number of genes commonly expressed between the 3 hypoxic conditions and substantially different from their respective controls. Some of these, which are known to be affected by hypoxia and/or in preeclampsia include VEGF; cytochrome P450; glutathione s-transferase pi (GSTpi); endothelin receptor type B; cadherin 3 (placental); coagulation factors II and VIII; E-selectin; colony stimulating factor 1; tumor protein p53; insulin-like growth factor binding protein 6; integrin α6 and others (38-43). Additionally, we have reported the increased expression of seven known HIF-1 regulated genes in the three hypoxic conditions relative to their respective controls (Table 2) . Array analyses showed significant differences in VEGF and integrin α6 (located outside areas A and B) and GSTpi (located inside areas A and B) between the hypoxia conditions and their respective controls.
We validated using qPCR that VEGF, a well-characterized hypoxia-induced gene (23), as well as integrin α6 were differentially expressed in hypoxia conditions versus control scenarios, increasing under reduced oxygenation. It is presently unknown if integrin α6 is a hypoxia-regulated gene, as such future studies should address if this gene is regulated by oxygen.
Studies have previously reported that VEGF expression is increased in placental tissue from preeclamptic and high altitude pregnancies; in addition in vitro studies have shown that VEGF is also augmented in primary isolated trophoblast cells cultured under reduced oxygenation (36, 44-47).
These findings corroborate our observation of increased VEGF expression in in vitro and in vivo models of placental hypoxia. The increased expression of VEGF in preeclampsia and in high altitude pregnancies could serve as a compensatory mechanism for reversal of impaired angiogenesis or as a direct physiologic adaptive response to reduced oxygenation (36, 46, 48). Studies have shown that trophoblast cells in preeclamptic and high altitude placentae as well as in explants cultured under low oxygen (3%) exhibit an undifferentiated proliferative phenotype (2, 3, 8, 36, 49) . Interestingly, the expression of integrin α6, previously reported to be restricted to undifferentiated/proliferative cytotrophoblast cells (50), is increased in the current experimental models, a finding that support the idea that under hypoxia conditions trophoblast cells maintain an immature phenotype. Finally, we should point out that preeclampsia is also a condition characterized by oxidative stress (27).
Interestingly, it has been reported that expression of glutathione s-transferases pi, a member of a family of enzymes with peroxidase activity, is increased in preeclamptic pregnancies as well as under hypoxic conditions in carcinogenic cell lines and in rats exposed to hypoxia (51-54). Our results agree with these observations and may highlight a role for this enzyme as a compensatory mechanism to prevent further oxidative damage under reduced oxygenation. Transition from an in vivo environment to a more minimalist in vitro experimental model often results in loss of physiological parameters that may adversely affect the integrity and reliability of the experiment. In this study we have shown that 
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